Administrative, Statistical, and Regulatory
Administrative, Statistical, and Regulatory
批准号:
7646823
负责人:
Pawel Kalinski
金额:
$14.73万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2014-03-31
关键词:
AwarenessBasic ScienceBiometryBiostatistics CoreClinicalClinical ResearchClinical TrialsCommunicationDataEnsureEpidemiologic StudiesEthicsGrantImmune responseIn VitroInformaticsInvestigationLaboratoriesLightMalignant NeoplasmsManuscriptsOccupational activity of managing financesPhasePhase I Clinical TrialsProgress ReportsReportingResearchResearch PersonnelResearch Project GrantsSafetyScientistServicesT-LymphocyteTreatment EfficacyUniversity of Pittsburgh Cancer InstituteWorkWritingabstractingbasebehavioral healthcancer preventioncancer therapydata sharingdesignin vivomeetingsoncologyprogramsprotocol developmentresearch studysoundtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Biostatistics component of the Administrative-Biostatistics Core will reside within the University of
Pittsburgh Cancer Institute's (UPCI) Biostatistics Facility, which provides clinical and basic-science
investigators in UPCI with statistical expertise in design, analysis, and reporting of cancer-related research
studies. These cover basic-science studies; phase I and phase II oncology clinical trials; epidemiologic
studies, including those related to cancer prevention and awareness; and investigations of behavioral and
health sequelae of cancer treatment. Biostatistics will support all three research projects. We will collaborate
with investigators on statistical aspects of the design of in vitro and in vivo laboratory-based studies as new
data come to light, and perform both exploratory and confirmatory statistical analyses of the resulting data
from key experiments. For the clinical trials that are planned in Project 1 and Project 3, we will collaborate
with basic scientists and clinicians on finalizing the development of protocols that are methodologically
sound, and that will pass scientific, ethical, and regulatory review. We will perform interim analyses of safety
for the clinical trials, and final analyses of their data on safety, immune response, and treatment efficacy. We
will work with the project investigators, UPCI Informatics, and with UPCI Clinical Research Services to
ensure that the requisite laboratory and clinical-trial data are available for statistical analyses. We will
collaborate with the project investigators in writing and preparing progress reports, abstracts, manuscripts,
and presentations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
-
批准号:10362635
-
项目类别:
-
资助金额:$287.59万
-
财政年份:2020
-
负责人:Pawel Kalinski
-
依托单位:
Core A: Administrative Core
-
批准号:10362704
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2020
-
负责人:Pawel Kalinski
-
依托单位:
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
-
批准号:10362700
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2020
-
负责人:Pawel Kalinski
-
依托单位:
IRP-3
-
批准号:10171149
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
-
批准号:8485810
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
IRP-3
-
批准号:10473682
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
Administrative, Statistical, and Regulatory
-
批准号:8518924
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2012
-
负责人:Pawel Kalinski
-
依托单位:
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
-
批准号:8518921
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2012
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8248336
-
项目类别:
-
资助金额:$165.18万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8518920
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8469287
-
项目类别:
-
资助金额:$143.7万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:7813976
-
项目类别:
-
资助金额:$122.96万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
-
批准号:7646820
-
项目类别:
-
资助金额:$22.78万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8045467
-
项目类别:
-
资助金额:$120.41万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:7633473
-
项目类别:
-
资助金额:$109.12万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
-
批准号:7408308
-
项目类别:
-
资助金额:$15.23万
-
财政年份:2007
-
负责人:Pawel Kalinski
-
依托单位:
Polarized DC as Melanoma Vaccine: Phase 1 Evaluation
-
批准号:6936950
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
Polarized DC as Melanoma Vaccine: Phase 1 Evaluation
-
批准号:7060766
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
NK CELLS INDUCE DCI-MEDIATED ANTI-TUMOR IMMUNITY
-
批准号:7128909
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
Regulation of DC Activity by Memory and Effector CD8+ T Cells
-
批准号:7741148
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2003
-
负责人:Pawel Kalinski
-
依托单位:
海外基金